HKSE - Delayed Quote HKD
CKLIFE SCIENCES (0775.HK)
0.930
+0.030
+(3.33%)
At close: May 2 at 4:08:23 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
353,534
353,534
514,181
363,659
423,575
Investing Cash Flow
-96,645
-96,645
-67,961
-22,119
-257,884
Financing Cash Flow
-341,975
-341,975
-477,953
-515,340
-220,081
End Cash Position
553,970
553,970
664,320
691,934
890,801
Capital Expenditure
-199,470
-199,470
-291,828
-216,969
-217,248
Issuance of Debt
1,365,601
1,365,601
3,187,878
1,224,000
1,150,000
Repayment of Debt
-1,300,000
-1,300,000
-3,195,431
-1,407,007
-1,100,000
Free Cash Flow
154,064
154,064
222,353
146,690
206,327
12/31/2021 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1177.HK SINO BIOPHARM
3.970
+1.53%
1801.HK INNOVENT BIO
54.900
+2.14%
2171.HK CARsgen Therapeutics Holdings Limited
15.940
+2.57%
2142.HK HBM Holdings Limited
8.810
+2.44%
9966.HK Alphamab Oncology
7.850
+21.52%
1877.HK JUNSHI BIO
16.260
-0.49%
1672.HK ASCLETIS-B
6.550
+3.15%
9995.HK RemeGen Co., Ltd.
41.400
+8.80%
1530.HK 3SBIO
13.420
+12.21%
2269.HK WuXi Biologics (Cayman) Inc.
24.100
+5.70%